Your Health, We Care
Release date: 2026-01-05 14:36:00 Recommended: 2
It is indicated for the treatment of pulmonary arterial hypertension (PAH) in adults and children aged 3 years and older, which can improve exercise tolerance and delay clinical deterioration.
